Nutra Pharma Corp
NPHC· OTC
NPHCNutra Pharma Corp
Filed Nov 21, 2012 · 10-Q · 235 days after period end · 0001144204-12-064585
| Metric | Q1 2012 | Q1 2011 |
|---|---|---|
| Revenue | $14.93K | $120.27K |
| Net Income | -$1.09M | -$638.23K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
ended Mar 31, 2012 · filed Nov 21, 2012 · 235 d after period end
